Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis.

Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis.

Item
http://www.wikidata.org/entity/Q35410898
Appetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumorsMalignant perivascular epithelioid cell tumor (PEComa) of the femur: a case report and literature reviewThe mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.Diffuse Cystic Lung Disease. Part I.(18)F-FDG PET/CT in detection of sarcomatous degeneration of renal angiomyolipoma in setting of tuberous sclerosisClinically relevant imaging in tuberous sclerosis.Glucose deprivation in tuberous sclerosis complex-related tumors.The role of (18)F-FDG PET/CT imaging in patient with malignant PEComa treated with mTOR inhibitorAnalysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.Lymphangioleiomyomatosis - a wolf in sheep's clothing.Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization.Advances in the diagnosis of pleural disease in lung cancer.Doctors' attitudes towards prescribing opioids for refractory dyspnoea: a single-centred study.Emerging biomarkers of lymphangioleiomyomatosis.Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection.Tuberous sclerosis complex renal disease.
P2860

Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis.

Item
http://www.wikidata.org/entity/Q35410898
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Utility of [18F]2-fluoro-2-deo ...... ated lymphangioleiomyomatosis.
@ast
Utility of [18F]2-fluoro-2-deo ...... ated lymphangioleiomyomatosis.
@en
type
label
Utility of [18F]2-fluoro-2-deo ...... ated lymphangioleiomyomatosis.
@ast
Utility of [18F]2-fluoro-2-deo ...... ated lymphangioleiomyomatosis.
@en
prefLabel
Utility of [18F]2-fluoro-2-deo ...... ated lymphangioleiomyomatosis.
@ast
Utility of [18F]2-fluoro-2-deo ...... ated lymphangioleiomyomatosis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Utility of [18F]2-fluoro-2-deo ...... iated lymphangioleiomyomatosis
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932